Target intelligence / Profile preview

Physiological small molecules

Molecular classification
Other
01

Overview

Physiological small molecules represent a vast and heterogeneous group of endogenous compounds, typically with a molecular weight under 900 Daltons, that are integral to biological processes. This category includes essential substances such as amino acids, fatty acids, sugars, vitamins, minerals, and signaling molecules like hormones and neurotransmitters (NIH, 2023). Because the term encompasses thousands of distinct chemical entities with diverse biological roles, it is considered a classification category rather than a specific therapeutic target. In pharmacology, these molecules often serve as the natural ligands for receptors or substrates for enzymes; therapeutic intervention usually involves modulating the concentration of a specific molecule or targeting the proteins that interact with them (PubChem, 2024). Consequently, "Physiological small molecules" is too broad to be used as a specific target for drug discovery or structured bioactivity data. Analysts should instead focus on specific members of this class, such as adenosine or cortisol, and their respective cognate receptors or metabolic enzymes (IUPHAR/BPS, 2023).

Other names
Endogenous small moleculesMetabolitesEndogenous ligandsBioactive small moleculesLow molecular weight physiological compounds
02

Mechanism of action

Not applicable as this is a broad category of substances rather than a single therapeutic target.

03

Biological functions

MetabolismCell signalingHomeostasisSignal transduction
04

Disease associations

Metabolic disorderEndocrine diseaseNutritional deficiency
05

Safety considerations

Disruption of metabolic homeostasisOff-target effects due to lack of molecular specificitySystemic toxicity

Beyond the preview

Go deeper on Physiological small molecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological small molecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call